title: Adequate exposure to tacrolimus with sublingual administration in pediatric liver transplant patients.
authors.forename: Natalia
authors.initials: N
authors.lastname: Riva
authors.forename: María E
authors.initials: ME
authors.lastname: Galván
authors.forename: Paulo
authors.initials: P
authors.lastname: Cáceres-Guido
authors.forename: Marcelo
authors.initials: M
authors.lastname: Dip
authors.forename: Nieves
authors.initials: N
authors.lastname: Licciardone
authors.forename: Oscar
authors.initials: O
authors.lastname: Imventarza
authors.forename: Paula
authors.initials: P
authors.lastname: Schaiquevich
authors.forename: Daniel
authors.initials: D
authors.lastname: Buamscha
mesh_terms: D000286:Administration, Sublingual; D000367:Age Factors; D001656:Biliary Atresia / Q000601:surgery*; D065095:Calcineurin Inhibitors / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics; D002648:Child; D002675:Child, Preschool; D016903:Drug Monitoring / Q000379:methods; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics; D007223:Infant; D016031:Liver Transplantation / Q000009:adverse effects; D008297:Male; D012189:Retrospective Studies; D016559:Tacrolimus / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics; D016896:Treatment Outcome
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016559:Tacrolimus